Salem Investment Counselors Inc Crispr Therapeutics Ag Transaction History
Salem Investment Counselors Inc
- $3.07 Billion
- Q2 2025
A detailed history of Salem Investment Counselors Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Salem Investment Counselors Inc holds 302 shares of CRSP stock, worth $18,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
302
Previous 302
-0.0%
Holding current value
$18,144
Previous $14,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CRSP
# of Institutions
481Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$611 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$365 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$228 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$167 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.54MShares$153 Million1.16% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.69B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....